{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:20:25Z","timestamp":1790274025098,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0210101"],"award-info":[{"award-number":["JP24fk0210101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama221414"],"award-info":[{"award-number":["JP24ama221414"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajpath.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:16:24Z","timestamp":1744917384000},"page":"1328-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Laminin-\u03b32\u2013NR6A1 Fusion Protein Promotes Metastatic Potential in Non\u2013Small-Cell Lung Carcinoma Cells without Epidermal Growth Factor Receptor Mutation"],"prefix":"10.1016","volume":"195","author":[{"given":"Ryo","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozora","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-1060","authenticated-orcid":false,"given":"Nobuaki","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4539-888X","authenticated-orcid":false,"given":"Naohiko","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.03.006_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1349-7006.2006.00150.x","article-title":"Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion","volume":"97","author":"Miyazaki","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2019.09.026","article-title":"Laminin 332 in cancer: when the extracellular matrix turns signals from cell anchorage to cell movement","volume":"62","author":"Rousselle","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/cas.13261","article-title":"Serum monomeric laminin-gamma2 as a novel biomarker for hepatocellular carcinoma","volume":"108","author":"Kiyokawa","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib4","first-page":"5596","article-title":"Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells","volume":"59","author":"Koshikawa","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib5","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/cas.13089","article-title":"Highly sensitive detection of invasive lung cancer cells by novel antibody against amino-terminal domain of laminin gamma2 chain","volume":"107","author":"Miyazaki","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063682","article-title":"LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis","volume":"12","author":"Fu","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajpath.2025.03.006_bib7","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.21037\/atm-21-4507","article-title":"LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ajpath.2025.03.006_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajg.2024.07.006","article-title":"Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma","volume":"25","author":"Dai","year":"2024","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00432-024-05720-7","article-title":"LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K\/Akt signaling pathway","volume":"150","author":"Cheng","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.7314\/APJCP.2015.16.5.2099","article-title":"Expression of laminingamma2 in extrahepatic cholangiocarcinoma tissues and its influence on tumor invasion and metastasis","volume":"16","author":"Li","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ajpath.2025.03.006_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.31758","article-title":"Serum laminin gamma2 monomer as a diagnostic and predictive biomarker for hepatocellular carcinoma","volume":"74","author":"Yamashita","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.006_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/cdd.2014.228","article-title":"LAMC2 enhances the metastatic potential of lung adenocarcinoma","volume":"22","author":"Moon","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajpath.2025.03.006_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/carcin\/bgab011","article-title":"LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma","volume":"42","author":"Okada","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41417-023-00654-7","article-title":"LAMC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer","volume":"30","author":"Tong","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ajpath.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1083\/jcb.148.3.615","article-title":"Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5","volume":"148","author":"Koshikawa","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1083\/jcb.200208145","article-title":"Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution","volume":"161","author":"Schenk","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib17","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1111\/cas.16265","article-title":"Hepatocyte transformation is induced by laminin gamma2 monomer","volume":"115","author":"Funahashi","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0006-291X(03)00452-2","article-title":"Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration","volume":"303","author":"Pirila","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2025.03.006_bib19","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1111\/cas.15149","article-title":"Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma","volume":"112","author":"Hoshino","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Martinez-Jimenez","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/ol.2024.14855","article-title":"Patients with non-small cell lung cancer with the exon 21 L858R mutation: from distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (review)","volume":"29","author":"Liu","year":"2025","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.21037\/tcr-23-956","article-title":"Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1342086","article-title":"NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy","volume":"15","author":"Raskova Kafkova","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13148-021-01046-0","article-title":"Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy","volume":"13","author":"Lodewijk","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.ajpath.2025.03.006_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13148-023-01574-x","article-title":"Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity","volume":"15","author":"Hu","year":"2023","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.ajpath.2025.03.006_bib26","first-page":"7","article-title":"Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues","volume":"50 Suppl 2","author":"Mizushima","year":"1998","journal-title":"Horm Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib27","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1158\/0008-5472.CAN-14-2798","article-title":"Proteolysis of EphA2 converts it from a tumor suppressor to an oncoprotein","volume":"75","author":"Koshikawa","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib28","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1111\/cas.14665","article-title":"NH(2) -terminal fragment of ZF21 protein suppresses tumor invasion via inhibiting the interaction of ZF21 with FAK","volume":"111","author":"Nagano","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/jbc.M411824200","article-title":"Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain","volume":"280","author":"Koshikawa","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2025.03.006_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154943","article-title":"Targeting mutations in cancer","volume":"132","author":"Waarts","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.03.006_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molmed.2023.03.007","article-title":"Cancer driver mutations: predictions and reality","volume":"29","author":"Ostroverkhova","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ajpath.2025.03.006_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-020-2175-2","article-title":"Landscape and function of multiple mutations within individual oncogenes","volume":"582","author":"Saito","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.03.006_bib33","article-title":"Association of mutation profiles with metastasis in patients with non-small cell lung cancer","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib34","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"North-East Japan Study Group: Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.03.006_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2025.03.006_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1349-7006.2001.tb01081.x","article-title":"Sole expression of laminin gamma 2 chain in invading tumor cells and its association with stromal fibrosis in lung adenocarcinomas","volume":"92","author":"Kagesato","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib37","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/1078-0432.CCR-09-2425","article-title":"A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies","volume":"16","author":"Kuenen","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13058-018-1046-3","article-title":"BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion","volume":"20","author":"Sethuraman","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1349-7006.2006.00188.x","article-title":"Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy","volume":"97","author":"Miyamoto","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jtho.2020.01.001","article-title":"Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer","volume":"15","author":"Arai","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cas.13111","article-title":"Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors","volume":"108","author":"Taniguchi","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/BJ20150039","article-title":"Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain","volume":"467","author":"Richards","year":"2015","journal-title":"Biochem J"},{"key":"10.1016\/j.ajpath.2025.03.006_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/ol.2022.13397","article-title":"EML4-ALK fusion gene in non-small cell lung cancer","volume":"24","author":"Lei","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2025.03.006_bib44","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/1078-0432.CCR-21-0032","article-title":"Spectrum of mechanisms of resistance to crizotinib and lorlatinib in ROS1 fusion-positive lung cancer","volume":"27","author":"Lin","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.03.006_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1238093","article-title":"Progress of non-small-cell lung cancer with ROS1 rearrangement","volume":"10","author":"Yang","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ajpath.2025.03.006_bib46","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.19.02551","article-title":"State-of-the-art strategies for targeting RET-dependent cancers","volume":"38","author":"Subbiah","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2025.03.006_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:17:35Z","timestamp":1778653055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0002944025001130"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.03.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laminin-\u03b32\u2013NR6A1 Fusion Protein Promotes Metastatic Potential in Non\u2013Small-Cell Lung Carcinoma Cells without Epidermal Growth Factor Receptor Mutation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}